Elanco Animal Health Incorporated (ELAN) vs Viatris Inc. (VTRS)

Elanco Animal Health Incorporated and Viatris Inc. are both Drug Manufacturers Specialty & Generic companies. Viatris Inc. is the larger, with a market value of $20.9B against $11.8B — 1.8× the size. Elanco Animal Health Incorporated grew revenue faster over the last twelve months: 12.0% against 4.40%. Viatris Inc. has the higher net margin (−2.79% vs −3.96%) and the lower return on invested capital (−0.20% vs 0.51%). Across the 20 metrics below, Viatris Inc. leads on 11 and Elanco Animal Health Incorporated on 9.

Valuation

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 2.34 1.47 2.11
P/B 1.79 1.52 1.78
Price to free cash flow 32.95 11.48 16.14
EV/EBITDA 19.58 12.58 12.58
EV/Sales 3.02 2.32 2.73
Earnings yield (1.74%) (1.93%) (4.38%)
Free cash flow yield 3.03% 8.71% 0.00%

Profitability

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
Gross margin 55.36% 34.83% 53.94%
Operating margin 1.61% (0.59%) 0.00%
Net margin (3.96%) (2.79%) 0.00%
Free cash flow margin 7.55% 12.83% 0.00%
Return on equity (2.98%) (2.75%) (0.40%)
Return on assets (1.46%) (1.12%) (3.32%)
Return on invested capital 0.51% (0.20%) 0.00%

Growth

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 11.95% 4.40% 10.01%
EPS growth (last fiscal year) (169.12%) (466.04%) 49.06%
Revenue growth, 5-year CAGR 7.59% 3.66% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
Debt to equity 0.59 0.94 0.05
Current ratio 2.05 1.58 2.31
Net debt to EBITDA 5.00 4.92 0.97

Dividend

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
Dividend yield — 2.57% 1.57%
Payout ratio — — 0.27

Size

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
Market cap 11.76b 20.93b 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack